{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:02:38Z","timestamp":1774360958161,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T00:00:00Z","timestamp":1253664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> This study aimed to investigate the effects of preoperative intravitreal bevacizumab (IVB) on outcomes in trabeculectomy for neovascular glaucoma (NVG).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Charts for 52 NVG eyes of 52 consecutive patients who received primary trabeculectomy with mitomycin C (MMC) were reviewed. Postoperative follow\u2010up periods for all patients were \u2265\u20034\u2003months. Thirty\u2010two consecutive eyes were treated without IVB (control group) and 20 consecutive eyes received IVB (1.25\u2003mg) 10\u2003\u00b1\u200311\u2003days before trabeculectomy (IVB group). The main outcome measures were postoperative intraocular pressure (IOP) and incidence of postoperative complications. Surgical success was defined as IOP&lt;\u200321\u2003mmHg with or without medication (qualified or complete success, respectively). Failure was defined as IOP exceeding these criteria, phthisis bulbi, loss of light perception or additional glaucoma surgeries. Kaplan\u2013Meier survival analysis with the log\u2010rank test was performed to compare surgical success rates between the two groups.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Complete and qualified success rates at 6\u2003months were 95% versus 50% and 95% versus 75% in the IVB and control groups, respectively. The IVB group achieved significantly better surgical success rates than the control group (complete success, p\u2003&lt;\u20030.001; qualified success, p\u2003=\u20030.026). Postoperative hyphaema on day\u20031 or hyphaema with a duration of &gt;\u20031\u2003week occurred significantly less frequently in the IVB group than in the control group (p\u2003=\u20030.009, p\u2003=\u20030.014, respectively). The incidence of serious complications such as endophthalmitis, phthisis bulbi and a marked decrease in visual acuity did not increase in the IVB group.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> This retrospective study showed that preoperative IVB decreased postoperative hyphaema and increased surgical success rates, and thus may be an effective adjunct to trabeculectomy in NVG.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2009.01648.x","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T10:37:38Z","timestamp":1253702258000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma"],"prefix":"10.1111","volume":"88","author":[{"given":"Yoshiaki","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Higashide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412013312203"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701587"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.02.037"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200603000-00016"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.064"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-007-9105-2"},{"key":"e_1_2_5_8_1","article-title":"Bevacizumab as adjuvant for neovascular glaucoma","author":"Beutel J","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.4.578"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.12.1644"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/112067210801800214","article-title":"Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma","volume":"18","author":"Chalam KV","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.47102\/annals-acadmedsg.V37N1p72","article-title":"Intraocular Avastin (bevacizumab) for neovascularization of the iris and neovascular glaucoma","volume":"37","author":"Cheng JY","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2007.01521.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03278.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200603000-00017"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181679c0b"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000212270.27359.64"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-005-0323-8"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0036"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis","volume":"142","author":"Grisanti S","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2001.15.2.98"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.06.066"},{"key":"e_1_2_5_23_1","article-title":"Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy","author":"Jiang Y","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"e_1_2_5_24_1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/1542-8877-20060301-11","article-title":"Intravitreal bevacizumab in a patient with neovascular glaucoma","volume":"37","author":"Kahook MY","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_5_25_1","first-page":"43","article-title":"The use of intravitreal bevacizumab in neovascular glaucoma: a case report","volume":"303","author":"Kelkar AS","year":"2007","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0047-5"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000095865"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.12.007"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000230425.31296.3b"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.151472"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.02.015"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00731.x"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00810.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00775-8"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140172010"},{"key":"e_1_2_5_36_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/112067210701700220","article-title":"Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion","volume":"17","author":"Vatavuk Z","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.02.026"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00800-5"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3180457c47"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01187.x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2009.01648.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2009.01648.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:59:27Z","timestamp":1698789567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2009.01648.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1755-3768.2009.01648.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01648.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]},"assertion":[{"value":"2010-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}